Opus Genetics (IRD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Opus Genetics (IRD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Opus Genetics |
350.17 Mn |
290.21 Mn |
- |
233.82% |
| Date | Value |
|---|
| Mar 31, 2026 |
233.82% |
| Dec 31, 2025 |
221.29% |
| Sep 30, 2025 |
211.71% |
| Jun 30, 2025 |
204.56% |
| Mar 31, 2025 |
198.34% |
| Dec 31, 2024 |
193.18% |
| Sep 30, 2023 |
-60.52% |
| Jun 30, 2023 |
-58.83% |
| Mar 31, 2023 |
-57.80% |
| Dec 31, 2022 |
-35.15% |
| Sep 30, 2022 |
-56.54% |
| Jun 30, 2022 |
-56.12% |
| Mar 31, 2022 |
-55.04% |
| Dec 31, 2021 |
-55.37% |
| Sep 30, 2021 |
-55.34% |
| Jun 30, 2021 |
-50.30% |
| Mar 31, 2021 |
-50.83% |
| Dec 31, 2020 |
-51.33% |
| Sep 30, 2020 |
-14.88% |
| Jun 30, 2020 |
-12.86% |
